Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma
Status:
Completed
Trial end date:
2021-03-05
Target enrollment:
Participant gender:
Summary
The purpose of this study to evaluate the feasibility of lenalidomide maintenance therapy in
patients with relapsed Hodgkin lymphoma after autologous transplant